Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP164499.RABbWybMjKC6GCYFHUBvqWdGw-T3AhujJGybUhWAgP4oU130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164499.RABbWybMjKC6GCYFHUBvqWdGw-T3AhujJGybUhWAgP4oU130_provenance.
• NP872237.RAARp0nkeryyafysVm8J5RLapSk83_E93TXKz6CUpOAEw130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872237.RAARp0nkeryyafysVm8J5RLapSk83_E93TXKz6CUpOAEw130_provenance.
• NP809378.RAUR2L6S3U0r0TOIb5ncO_qrtSfo-EIHbYrJ3VK8xZCTQ130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809378.RAUR2L6S3U0r0TOIb5ncO_qrtSfo-EIHbYrJ3VK8xZCTQ130_provenance.
• NP273870.RACz-OwuTQaaVQS-u9F-VH_qWSAzyA2lK93l7r2QyFtFE130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273870.RACz-OwuTQaaVQS-u9F-VH_qWSAzyA2lK93l7r2QyFtFE130_provenance.
• NP492869.RAlcHrHpp_rF2BCmiX-q4cYPIre2qv6xQ0ZeVvEqE4-Ko130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492869.RAlcHrHpp_rF2BCmiX-q4cYPIre2qv6xQ0ZeVvEqE4-Ko130_provenance.
• NP720109.RAmuSvkwqf9Q29-_TlWanx3b1bthIe_bgxXz5Wv0ll8dE130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720109.RAmuSvkwqf9Q29-_TlWanx3b1bthIe_bgxXz5Wv0ll8dE130_provenance.
• NP188920.RAF9fdgfwVz9pLz84XpgIJW7gTtQn4A3F7yxhqGPx-ss8130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188920.RAF9fdgfwVz9pLz84XpgIJW7gTtQn4A3F7yxhqGPx-ss8130_provenance.
• NP1389205.RARHTerbiEWoMqtXJaYgAWxOktgmi3_S2XfI3OCR9G6HI130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389205.RARHTerbiEWoMqtXJaYgAWxOktgmi3_S2XfI3OCR9G6HI130_provenance.
• NP1389209.RAf6jW4dHQQ49nME-rgYl4QKJi5ud0-IEnriMVgMHjdIQ130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389209.RAf6jW4dHQQ49nME-rgYl4QKJi5ud0-IEnriMVgMHjdIQ130_provenance.
• NP398436.RAnx6r3t5dQudsdD7UdzjhsRnWsY8YwNHTj_5wPVcrypc130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398436.RAnx6r3t5dQudsdD7UdzjhsRnWsY8YwNHTj_5wPVcrypc130_provenance.
• NP553179.RAl5qPh92MsoKCabN8s3NtvQnMkGUYiSjW08Zi9ril9L8130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553179.RAl5qPh92MsoKCabN8s3NtvQnMkGUYiSjW08Zi9ril9L8130_provenance.
• NP553431.RAtW1VP-qZ11UG4py-TNb0qmUvR6kEM15H1zLK57Jkn6s130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553431.RAtW1VP-qZ11UG4py-TNb0qmUvR6kEM15H1zLK57Jkn6s130_provenance.
• NP1389206.RAshss2LrGNPdKknRmc1QnnAiuvhD3cuyZhsJ5WCNR3YQ130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389206.RAshss2LrGNPdKknRmc1QnnAiuvhD3cuyZhsJ5WCNR3YQ130_provenance.
• NP1389210.RAjs8wXBQA-kcsjDmm8qQzZoeXQLfE6zUxJ3lGz9tcJRw130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389210.RAjs8wXBQA-kcsjDmm8qQzZoeXQLfE6zUxJ3lGz9tcJRw130_provenance.
• NP262093.RA7QS1ieSkJ4UYtVGqPRRFzThEZTCt_0xhGrWSRDrSIwk130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262093.RA7QS1ieSkJ4UYtVGqPRRFzThEZTCt_0xhGrWSRDrSIwk130_provenance.
• NP398668.RAMZseu4VGN_WqBei4-jReI20A6iqI5IIN7ziOCVfl1S0130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398668.RAMZseu4VGN_WqBei4-jReI20A6iqI5IIN7ziOCVfl1S0130_provenance.
• NP262916.RAHdrIUufwT-jPSjFppovyiM_IAT3UmpnWPIbLAFyq_NA130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262916.RAHdrIUufwT-jPSjFppovyiM_IAT3UmpnWPIbLAFyq_NA130_provenance.
• NP1389208.RAJzsR0Y2IZHvfkeJ8wCG6E5YC8tDO387FsHUWOTBuw0o130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389208.RAJzsR0Y2IZHvfkeJ8wCG6E5YC8tDO387FsHUWOTBuw0o130_provenance.
• NP1389207.RA7zOvBMcwz-pmefO1koIhhhkQZIwAy_axvK0TwF-M5cg130_assertion description "[Proven or potential transforming factors include the allelic loss of the MEN-1 suppressor gene at 11q13, the still unknown factor(s) associated with atrophic corporal gastritis in which overexpression of BCL-2 likely plays a favouring role by prolonging ECL exposure to mitogens, and agents with still unclarified role, such as basic fibroblast growth factor, human chorionic gonadotropin-alpha and transforming growth factor-alpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1389207.RA7zOvBMcwz-pmefO1koIhhhkQZIwAy_axvK0TwF-M5cg130_provenance.